{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:05:50Z","timestamp":1781715950431,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,17]]},"DOI":"10.7759\/cureus.111043","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:37:31Z","timestamp":1781714251000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Antenatal Presentation of a Novel Dnase2 Mutation in a Preterm Omani Neonate: Expanding the Clinical Spectrum of an Ultra-Rare Interferonopathy"],"prefix":"10.7759","author":[{"given":"Ruqaiya","family":"Al Jashmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marya","family":"Al Barumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiya","family":"Al- Abrawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyaa","family":"Al Mughairy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiman","family":"Al Jabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.631329","article-title":"Type I interferonopathies in children: an overview","volume":"9","author":"d'Angelo DM","year":"2021","unstructured":"d'Angelo DM, Di Filippo P, Breda L, Chiarelli F. Type I interferonopathies in children: an overview. Front Pediatr. 2021, 9:631329. 10.3389\/fped.2021.631329","journal-title":"Front Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-016-0094-4","article-title":"Type I interferonopathies in pediatric rheumatology","volume":"14","author":"Volpi S","year":"2016","unstructured":"Volpi S, Picco P, Caorsi R, Candotti F, Gattorno M. Type I interferonopathies in pediatric rheumatology. Pediatr Rheumatol Online J. 2016, 14:35. 10.1186\/s12969-016-0094-4","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.06220.x","article-title":"Type I interferonopathies: a novel set of inborn errors of immunity","volume":"1238","author":"Crow YJ","year":"2011","unstructured":"Crow YJ. Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci. 2011, 1238:91-8. 10.1111\/j.1749-6632.2011.06220.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2017.12.002","article-title":"Genetic interferonopathies: an overview","volume":"31","author":"Eleftheriou D","year":"2017","unstructured":"Eleftheriou D, Brogan PA. Genetic interferonopathies: an overview. Best Pract Res Clin Rheumatol. 2017, 31:441-59. 10.1016\/j.berh.2017.12.002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow YJ","year":"2022","unstructured":"Crow YJ, Stetson DB. The type I interferonopathies: 10 years on. Nat Rev Immunol. 2022, 22:471-83. 10.1038\/s41577-021-00633-9","journal-title":"Nat Rev Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv LB","year":"2014","unstructured":"Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol. 2014, 14:36-49. 10.1038\/nri3581","journal-title":"Nat Rev Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180139","article-title":"The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer","volume":"215","author":"Li T","year":"2018","unstructured":"Li T, Chen ZJ. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J Exp Med. 2018, 215:1287-99. 10.1084\/jem.20180139","journal-title":"J Exp Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview","volume":"213","author":"Rodero MP","year":"2016","unstructured":"Rodero MP, Crow YJ. Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med. 2016, 213:2527-38. 10.1084\/jem.20161596","journal-title":"J Exp Med"},{"key":"ref9","unstructured":"National Center for Biotechnology Information. DNASE2 deoxyribonuclease 2, lysosomal (Homo sapiens (human)). Gene ID. 1777. (2026). https:\/\/www.ncbi.nlm.nih.gov\/gene\/1777."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2003.08.022","article-title":"DNase II: genes, enzymes and function","volume":"322","author":"Evans CJ","year":"2003","unstructured":"Evans CJ, Aguilera RJ. DNase II: genes, enzymes and function. Gene. 2003, 322:1-15. 10.1016\/j.gene.2003.08.022","journal-title":"Gene"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01932-3","article-title":"Type I interferon-mediated autoinflammation due to DNase II deficiency","volume":"8","author":"Rodero MP","year":"2017","unstructured":"Rodero MP, Tesser A, Bartok E, et al.. Type I interferon-mediated autoinflammation due to DNase II deficiency. Nat Commun. 2017, 8:2176. 10.1038\/s41467-017-01932-3","journal-title":"Nat Commun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.822945","article-title":"Dysregulation of the cGAS-STING pathway in monogenic autoinflammation and lupus","volume":"13","author":"Woboma H","year":"2022","unstructured":"Woboma H, Shin DS, Chou J, Dedeo\u011flu F. Dysregulation of the cGAS-STING pathway in monogenic autoinflammation and lupus. Front Immunol. 2022, 13:822945. 10.3389\/fimmu.2022.822945","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2024-0294","article-title":"Children with type I interferonopathy: commonalities and diversities in a large patient cohort","volume":"51","author":"Haslak F","year":"2024","unstructured":"Haslak F, Kilic H, Sahin S, et al.. Children with type I interferonopathy: commonalities and diversities in a large patient cohort. J Rheumatol. 2024, 51:1208-17. 10.3899\/jrheum.2024-0294","journal-title":"J Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.11.020","article-title":"Janus kinase inhibition for autoinflammation in patients with DNASE2 deficiency","volume":"145","author":"Hong Y","year":"2020","unstructured":"Hong Y, Capitani M, Murphy C, et al.. Janus kinase inhibition for autoinflammation in patients with DNASE2 deficiency. J Allergy Clin Immunol. 2020, 145:701-705.e8. 10.1016\/j.jaci.2019.11.020","journal-title":"J Allergy Clin Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez GA","year":"2018","unstructured":"Sanchez GA, Reinhardt A, Ramsey S, et al.. JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest. 2018, 128:3041-52. 10.1172\/JCI98814","journal-title":"J Clin Invest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/481729-severe-antenatal-presentation-of-a-novel-dnase2-mutation-in-a-preterm-omani-neonate-expanding-the-clinical-spectrum-of-an-ultra-rare-interferonopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:37:34Z","timestamp":1781714254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/481729-severe-antenatal-presentation-of-a-novel-dnase2-mutation-in-a-preterm-omani-neonate-expanding-the-clinical-spectrum-of-an-ultra-rare-interferonopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.111043","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,17]]}}}